| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 439.034 | 419.046 | 378.312 | 363.224 | 318.274 | 309.203 | 7.567 | 8.402 | 8.405 | 8.401 |
| Total Income - EUR | 454.774 | 439.103 | 397.758 | 381.637 | 337.824 | 546.930 | 14.279 | 8.442 | 8.405 | 8.408 |
| Total Expenses - EUR | 451.102 | 425.551 | 392.123 | 370.971 | 325.708 | 330.554 | 6.005 | 6.680 | 4.318 | 6.990 |
| Gross Profit/Loss - EUR | 3.672 | 13.552 | 5.635 | 10.665 | 12.116 | 216.375 | 8.274 | 1.762 | 4.088 | 1.418 |
| Net Profit/Loss - EUR | 2.545 | 11.237 | 4.154 | 8.539 | 9.690 | 181.273 | 6.936 | 1.508 | 3.310 | 1.070 |
| Employees | 6 | 6 | 6 | 5 | 5 | 4 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacia Danielopolu Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.309 | 25.546 | 24.519 | 23.686 | 22.866 | 18.007 | 13.592 | 12.483 | 11.585 | 8.593 |
| Current Assets | 134.125 | 106.437 | 131.049 | 100.513 | 70.775 | 169.581 | 2.064 | 1.508 | 2.554 | 2.749 |
| Inventories | 68.020 | 64.760 | 51.877 | 42.108 | 54.143 | 0 | 340 | 0 | 0 | 0 |
| Receivables | 51.096 | 39.768 | 77.008 | 53.594 | 13.298 | 1.784 | 833 | 1.256 | 1.413 | 1.593 |
| Cash | 15.009 | 1.909 | 2.163 | 4.811 | 3.334 | 167.798 | 890 | 252 | 1.141 | 1.156 |
| Shareholders Funds | 60.528 | 15.691 | 21.817 | 17.291 | 27.483 | 12.404 | 15.493 | 13.675 | 13.418 | 11.122 |
| Social Capital | 11.249 | 11.134 | 10.945 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 | 10.052 |
| Debts | 87.906 | 116.292 | 133.751 | 106.908 | 66.159 | 175.185 | 163 | 316 | 721 | 220 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Danielopolu Srl